Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin
Lorenzo Arnaboldi, Alberto Corsini
Atherosclerosis Supplements (2015) Vol. 16, pp. 1-27
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Metabolic Syndrome
Dawn Harris Sherling, Parvathi Perumareddi, Charles H. Hennekens
Journal of Cardiovascular Pharmacology and Therapeutics (2017) Vol. 22, Iss. 4, pp. 365-367
Closed Access | Times Cited: 238
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
Massimiliano Ruscica, Nicola Ferri, Maciej Banach, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 17, pp. 3288-3304
Open Access | Times Cited: 106
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms
Piotr Chruściel, Amirhossein Sahebkar, Magdalena Rembek-Wieliczko, et al.
Atherosclerosis (2016) Vol. 253, pp. 194-208
Open Access | Times Cited: 167
The diabetogenic action of statins — mechanisms and clinical implications
D. J. Betteridge, Rafael Carmena
Nature Reviews Endocrinology (2015) Vol. 12, Iss. 2, pp. 99-110
Closed Access | Times Cited: 162
Adiponectin, lipids and atherosclerosis
Niki Katsiki, Christos S. Mantzoros, Dimitri P. Mikhailidis
Current Opinion in Lipidology (2017) Vol. 28, Iss. 4, pp. 347-354
Closed Access | Times Cited: 154
Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease
Lavinia Woodward, Ioannis Akoumianakis, Charalambos Antoniades
British Journal of Pharmacology (2016) Vol. 174, Iss. 22, pp. 4007-4020
Open Access | Times Cited: 133
Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes
Antonio J. Vallejo‐Vaz, Sreenivasa Rao Kondapally Seshasai, Kazumasa Kurogi, et al.
Atherosclerosis (2015) Vol. 241, Iss. 2, pp. 409-418
Closed Access | Times Cited: 112
Cholesterol metabolism, pancreatic β-cell function and diabetes
Carla Perego, Lorenzo Da Dalt, Angela Pirillo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 9, pp. 2149-2156
Open Access | Times Cited: 108
Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea
Jinkwon Kim, Hye Sun Lee, Kyung‐Yul Lee
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 50
Simple and novel icariin-loaded pro-glycymicelles as a functional food: physicochemical characteristics, in vitro biological activities, and in vivo experimental hyperlipidemia prevention evaluations
Qingchen Cui, Cuicui Wang, Liping Zhou, et al.
Food & Function (2023) Vol. 14, Iss. 21, pp. 9907-9919
Closed Access | Times Cited: 15
Clinical Pharmacology of Statins: an Update
Nicola Ferri, Alberto Corsini
Current Atherosclerosis Reports (2020) Vol. 22, Iss. 7
Closed Access | Times Cited: 37
Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction
Jah Yeon Choi, Cheol Ung Choi, Soon-Young Hwang, et al.
The American Journal of Cardiology (2018) Vol. 122, Iss. 6, pp. 922-928
Closed Access | Times Cited: 34
Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
Wei-Ting Liu, Chin Lin, Min‐Chien Tsai, et al.
Biomedicines (2020) Vol. 8, Iss. 11, pp. 499-499
Open Access | Times Cited: 31
Statins and their increased risk of inducing diabetes
Aris P. Agouridis, Michael S. Kostapanos, Moses Elisaf
Expert Opinion on Drug Safety (2015) Vol. 14, Iss. 12, pp. 1835-1844
Closed Access | Times Cited: 32
Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
Georgios Sfikas, Michael Psallas, Charalambos Koumaras, et al.
Current Vascular Pharmacology (2020) Vol. 19, Iss. 5, pp. 572-581
Closed Access | Times Cited: 26
Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions
Hossein Haghbin
Annals of Gastroenterology (2020)
Open Access | Times Cited: 24
Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study
Bahar Arıcan Tarım, Francesco Fıcı, İstemihan Tengiz, et al.
Yonsei Medical Journal (2023) Vol. 64, Iss. 3, pp. 175-175
Open Access | Times Cited: 9
Food and plant bioactives for reducing cardiometabolic disease: How does the evidence stack up?
Arrigo F.G. Cicero, Alessandro Colletti
Trends in Food Science & Technology (2017) Vol. 69, pp. 192-202
Closed Access | Times Cited: 27
Adiponectin in psoriasis and its comorbidities: a review
Ruiyang Bai, Adriana C. Panayi, Ruifang Wu, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Pitavastatin and HDL: Effects on plasma levels and function(s)
Angela Pirillo, Alberico L. Catapano
Atherosclerosis Supplements (2017) Vol. 27, pp. e1-e9
Open Access | Times Cited: 24
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature
Davide Noto, Marcello Arca, Patrizia Tarugi, et al.
Acta Diabetologica (2016) Vol. 54, Iss. 2, pp. 111-122
Closed Access | Times Cited: 20
Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets
Yahui Ding, Yuan Ma, Lin-Yan Qian, et al.
Oncotarget (2017) Vol. 8, Iss. 36, pp. 60673-60683
Open Access | Times Cited: 17
Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up
Han Saem Jeong, Soon Jun Hong, Serhim Son, et al.
Cardiovascular Diabetology (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Clinical Benefits of Pitavastatin: Focus On Patients With Diabetes Or at Risk of Developing Diabetes
Vivencio Barrios, Carlos Escobar
Future Cardiology (2016) Vol. 12, Iss. 4, pp. 449-466
Closed Access | Times Cited: 14
Statin use in prediabetic patients: rationale and results to date
Anastazia Kei, Evangelos C. Rizos, Moses Elisaf
Therapeutic Advances in Chronic Disease (2015) Vol. 6, Iss. 5, pp. 246-251
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top